| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
September 2022 - 53 Präparate |
|
| | | PI | | Zafrilla 2 mg | 2 x 14 | 39.48 | 61.70 | 10% | | Tabletten: Dienogestum 2 mg | Gedeon Richter (Schweiz) AG | B / SL / SG | FB | | G |  |
| | | PI | | Zafrilla 2 mg | 6 x 14 | 100.67 | 131.95 | 10% | | Tabletten: Dienogestum 2 mg | Gedeon Richter (Schweiz) AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ngenla 24 mg/ 1.2 ml | 1.2 ml | 284.60 | 343.10 | 10% | | Injektionslösung im Fertigpen: Somatrogonum 24mg / 1.2ml | Pfizer AG | A / SL | FB | | G |  |
L | | FI | | | Ngenla 60 mg/ 1.2 ml | 1.2 ml | 711.50 | 833.20 | 10% | | Injektionslösung im Fertigpen: Somatrogonum 60mg / 1.2ml | Pfizer AG | A / SL | FB | | G |  |
| | | | | Umckaloabo Direct | 21 x 800 mg | PA | PA | k.A. | | | Schwabe Pharma AG | D | FB | | G |  |
| | FI | | | Evusheld | 2 | PA | PA | k.A. | | Injektionslösung: Tixagevimabum 150mg / 1.5ml Injektionslösung: Cilgavimabum 150mg / 1.5ml | AstraZeneca AG | A | FB | | G |  |
| | | | | Striascan 74 MBq/ml | | PA | PA | k.A. | | Injektionslösung: Ioflupanum(123-I) zum Kalibrierungszeitpunkt 185MBq / 2.5ml | b.e.imaging.ag | A | FB | | G |  |
| | | | | Kaloba Direct | 21 x 800 mg | PA | PA | k.A. | | Granulat: Pelargonii Radicis Extractum Ethanolicum Fluidum (Pelargonium Sidoides dc., Radix) Der | Schwabe Pharma AG | D | FB | | G |  |
| | | | | Kaloba Direct | 36 x 800 mg | PA | PA | k.A. | | Granulat: Pelargonii Radicis Extractum Ethanolicum Fluidum (Pelargonium Sidoides dc., Radix) Der | Schwabe Pharma AG | D | FB | | G |  |
| | | | | Akynzeo IV 235 mg / 0.25 mg | | PA | PA | k.A. | | Infusionskonzentrat: 2 Wirkstoffe | Vifor (International) Inc. | B | FB | | G |  |
| | | | | Abirateron Viatris 500 mg | 56 | PA | PA | k.A. | | Filmtabletten: Abirateroni Acetas 500 mg | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Abirateron Viatris 1000 mg | 28 | PA | PA | k.A. | | Filmtabletten: Abirateroni Acetas 1000 mg | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg | 30 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B | FB | | G |  |
| | | | | Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg | 90 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B | FB | | G |  |
| | | | | Ezetimib Rosuvastatin Zentiva 10 mg / 20 mg | 30 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B | FB | | G |  |
| | | | | Ezetimib Rosuvastatin Zentiva 10 mg / 20 mg | 90 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 20mg/5mg/12,5mg | 28 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 20mg/5mg/12,5mg | 98 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 40mg/5 mg/12,5 mg | 28 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 40mg/5 mg/12,5 mg | 98 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris, 40mg/10mg/12,5mg | 28 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris, 40mg/10mg/12,5mg | 98 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 40mg/5mg/25mg | 28 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 40mg/5mg/25mg | 98 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 40mg/10mg/25mg | 28 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Olmesartan Amlodipin HCT Viatris 40mg/10mg/25mg | 98 | PA | PA | k.A. | | Filmtabletten: 3 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Sitagliptin Metformin axapharm 50 mg/500 mg | 56 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Axapharm AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin axapharm 50 mg/500 mg | 196 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Axapharm AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin axapharm 50 mg/850 mg | 56 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Axapharm AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin axapharm 50 mg/850 mg | 196 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Axapharm AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin axapharm 50 mg/1000 mg | 56 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Axapharm AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin axapharm 50 mg/1000 mg | 196 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Axapharm AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin Sandoz 50 mg/500 mg | 56 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin Sandoz 50 mg/850 mg | 56 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin Sandoz 50 mg/1000 mg | 56 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin Sandoz 50 mg/500 mg | 196 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin Sandoz 50 mg/850 mg | 196 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Sitagliptin Metformin Sandoz 50 mg/1000 mg | 196 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | PI | | Tavneos 10 mg | 30 | PA | PA | k.A. | | Kapseln: Avacopanum 10 mg | Vifor Fresenius Medical Care Renal Pharma Ltd | B | FB | | G |  |
| | FI | PI | | Tavneos 10 mg | 180 | PA | PA | k.A. | | Kapseln: Avacopanum 10 mg | Vifor Fresenius Medical Care Renal Pharma Ltd | B | FB | | G |  |
| | | | | Adler Euclim | 400 | PA | PA | k.A. | | Tabletten: 3 Wirkstoffe | Adler Pharma Helvetia AG | D | FB | | G |  |
| | | | | Adler Euclim | 1000 | PA | PA | k.A. | | Tabletten: 3 Wirkstoffe | Adler Pharma Helvetia AG | D | FB | | G |  |
| | | | | Bilastin Viatris 20 mg | 10 | PA | PA | k.A. | | Tabletten: Bilastinum 20 mg | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Bilastin Viatris 20 mg | 30 | PA | PA | k.A. | | Tabletten: Bilastinum 20 mg | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Bilastin Viatris 20 mg | 50 | PA | PA | k.A. | | Tabletten: Bilastinum 20 mg | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Vildagliptin NOBEL 50 mg | 28 | PA | PA | k.A. | | Tabletten: Vildagliptinum 50 mg | NOBEL Pharma Schweiz AG | B | FB | | G |  |
| | | | | Vildagliptin NOBEL 50 mg | 112 | PA | PA | k.A. | | Tabletten: Vildagliptinum 50 mg | NOBEL Pharma Schweiz AG | B | FB | | G |  |
| | FI | PI | | Visanne 2.0 mg | 2 x 14 | PA | PA | k.A. | | Tabletten: Dienogestum 2 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Visanne 2.0 mg | 2 x 14 | PA | PA | k.A. | | Tabletten: Dienogestum 2 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Visanne 2.0 mg | 6 x 14 | PA | PA | k.A. | | Tabletten: Dienogestum 2 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Visanne 2.0 mg | 6 x 14 | PA | PA | k.A. | | Tabletten: Dienogestum 2 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | | PI | | Zafrilla 2 mg | 12 x 14 | PA | PA | k.A. | | Tabletten: Dienogestum 2 mg | Gedeon Richter (Schweiz) AG | B | FB | | G |  |
| | | | | Merional HG 900 I.E. Multidose | 1 + | PA | PA | k.A. | | polvere e soluzione per soluzione iniettabile: Menotropinum 900 UI | IBSA Institut Biochimique SA | A | FB | | G |  |